UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘More accurate diagnosis of preeclampsia possible’
Preeclampsia is one of the top three risks of pregnancy with premature obst...
by Park Gi-taek
|
2017-12-14 11:38
라인
‘New cancer drugs need 601 days to get insurance in Korea’
Newly approved cancer drugs need at least 601 days to receive insurance ben...
by So Jae-hyeon
|
2017-12-14 11:27
라인
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo
|
2017-12-14 10:52
라인
Koreans in their 20s most susceptible to hepatitis A: study
New research shows nine out of 10 young adults in Korea do not have antibod...
by Marian Chu
|
2017-12-13 18:18
라인
MGmed to change name to Cancer Rop
Korean pharmaceutical MGmed decided to change the company’s name to Cancer ...
by Marian Chu
|
2017-12-13 18:14
라인
[Column] Look ahead 10 years before investing
It is said that waiting is the answer when it comes to new drugs that usual...
by Song Hyoung-gon
|
2017-12-13 17:48
라인
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo
|
2017-12-13 17:17
라인
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon
|
2017-12-13 15:23
라인
Janssen says its multiple myeloma drug combo halves death risk
Janssen, a Johnson & Johnson division, said a combination therapy with DARZ...
by Marian Chu
|
2017-12-13 15:22
라인
FDA approves treatment for eosinophilic granulomatosis with polyangiitis
The U.S. Food and Drug Administration (FDA) Wednesday approved GlaxoSmithKl...
by Lee Han-soo
|
2017-12-13 14:35
라인
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study
Bluebird Bio and Celgene posted phase 1 results of investigational drug bb2...
by Marian Chu
|
2017-12-13 14:30
라인
AstraZeneca to test Imfinzi on lung cancer patients
AstraZeneca is to conduct a clinical trial on anti-cancer immunotherapy Imf...
by Lee Hye-seon
|
2017-12-13 14:20
라인
Wholesalers sweat over drug companies’ forceful sales
Local wholesalers of pharmaceutical products are experiencing distress at t...
by So Jae-hyeon
|
2017-12-13 11:33
라인
Misdiagnosis of Segawa syndrome sparks public debate
A controversy arose over a 20-year-old woman, who had been bound – en...
by Lee Han-soo
|
2017-12-13 11:26
라인
Hanmi leads erectile dysfunction drug sales
Teva Pharmaceutical and Pfizer said Monday they will launch generic version...
by Marian Chu
|
2017-12-12 17:49
라인
What is healthcare like up north?
A North Korean soldier who crossed over to the South offered a glimpse into...
by Marian Chu
|
2017-12-12 17:25
라인
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun
|
2017-12-12 15:59
라인
Bio-industry output sees steady growth
The Ministry of Trade, Industry and Energy (MOTIE) said Tuesday that the do...
by Lee Han-soo
|
2017-12-12 15:52
라인
Drugmakers lead job growth in manufacturing sector
The pharmaceutical industry has led the growth of jobs in the manufacturing...
by So Jae-hyeon
|
2017-12-12 15:12
라인
President Moon promises proper reimbursements for physicians
President Moon Jae-in promised that the government would guarantee an appro...
by Choi Gwang-seok
|
2017-12-12 14:26
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top